NASDAQ · Price History

Kailera Therapeutics, Inc. (KLRA) Stock Price History & Returns

$12.20 NASDAQ: KLRA Market Cap $1.58B

Price history through Nov 17, 2026 · Source: Yahoo Finance (adjusted closes) (methodology)

How Kailera Therapeutics, Inc. (KLRA) has performed, year by year and over each trailing period. Price history only — total return to a shareholder would also include dividends.

The share price of $12.20 sits 13% of the way up a 52-week range of $9.76 to $28.23; 56.8% below the 52-week high; below its 50-day moving average of $12.49; below its 200-day average of $17.61; a beta of 0.50 means it has historically moved less than the market.

Total return

Price change over each trailing period, not annualised.

PeriodReturn
3 months-33.4%
6 months-42.1%

Monthly closing prices

The last 8 months, newest first. 1 of 7 months closed higher than the month before. Each figure is the last close in that month.

MonthCloseChange
November 2026$12.20-5.1%
October 2026$12.86+12.6%
September 2026$11.42-25.8%
August 2026$15.40-9.1%
July 2026$16.94-23.1%
June 2026$22.03-4.0%
May 2026$22.94-8.2%
April 2026$25.00—

Kailera Therapeutics, Inc. (KLRA) price history — frequently asked questions

How has Kailera Therapeutics, Inc. performed over the last year?

Kailera Therapeutics, Inc. (KLRA) has risen 0.0% over the last twelve months, measured on price alone.

What is Kailera Therapeutics, Inc.'s five-year return?

Over five years the KLRA share price has gained 0.0%, excluding dividends.

What is Kailera Therapeutics, Inc.'s 52-week range?

Over the last year Kailera Therapeutics, Inc. (KLRA) has traded between $9.76 and $28.23.

Price returns of other Biotechnology stocks

VRTX 1-year +22.4%REGN 1-year +38.2%MRNA 1-year +740.3%RVMD 1-year +137.0%ROIV 1-year +92.3%INSM 1-year -36.3%UTHR 1-year +27.9%INCY 1-year +14.8%ALNY 1-year -63.6%ASND 1-year +33.4%All Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.